Correlation Between Citigroup and Knight Therapeutics
Can any of the company-specific risk be diversified away by investing in both Citigroup and Knight Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Knight Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Knight Therapeutics, you can compare the effects of market volatilities on Citigroup and Knight Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Knight Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Knight Therapeutics.
Diversification Opportunities for Citigroup and Knight Therapeutics
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Citigroup and Knight is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Knight Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Knight Therapeutics and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Knight Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Knight Therapeutics has no effect on the direction of Citigroup i.e., Citigroup and Knight Therapeutics go up and down completely randomly.
Pair Corralation between Citigroup and Knight Therapeutics
Taking into account the 90-day investment horizon Citigroup is expected to generate 1.27 times more return on investment than Knight Therapeutics. However, Citigroup is 1.27 times more volatile than Knight Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Knight Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 6,134 in Citigroup on August 29, 2024 and sell it today you would earn a total of 841.00 from holding Citigroup or generate 13.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Citigroup vs. Knight Therapeutics
Performance |
| Timeline |
| Citigroup |
| Knight Therapeutics |
Citigroup and Knight Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citigroup and Knight Therapeutics
The main advantage of trading using opposite Citigroup and Knight Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Knight Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Knight Therapeutics will offset losses from the drop in Knight Therapeutics' long position.| Citigroup vs. JPMorgan Chase Co | Citigroup vs. Wells Fargo | Citigroup vs. Toronto Dominion Bank | Citigroup vs. Nu Holdings |
| Knight Therapeutics vs. Crescita Therapeutics | Knight Therapeutics vs. Cannara Biotech | Knight Therapeutics vs. Lowell Farms | Knight Therapeutics vs. Aion Therapeutic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |